Search Within

Shanu Modi

Formats
  1. Meeting Abstract (150)
  2. Journal Article (99)
  3. Review (11)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Breast Medicine Service (265)
  2. Department of Medicine (265)
  3. Solid Tumor Oncology Division (265)
  4. Survivorship Research (113)
  5. GSK Faculty (104)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (88)

More Groups

People
  1. Clifford Hudis (79)
  2. Larry Norton (53)
  3. Sarat Chandarlapaty (49)
  4. Sujata Patil (44)
  5. Chau Dang (41)
  6. Komal Jhaveri (34)

More People

Years
  1. 2025 (5)
  2. 2024 (23)
  3. 2023 (15)
  4. 2022 (19)
  5. 2021 (19)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (65)
  2. Cancer Research (50)
  3. Annals of Oncology (27)
  4. Breast Cancer Research and Treatment (14)
  5. Clinical Cancer Research (10)
  6. Clinical Breast Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (66)
  2. American Association for Cancer Research (64)
  3. Oxford University Press (33)
  4. Elsevier Inc. (19)
  5. Springer (18)
  6. Nature Publishing Group (13)

More Publishers

Results (265)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2-advanced/metastatic breast cancer: Results from a Phase Ib clinical trial
    Meeting Abstract

    Bardia, A.; Chavez-MacGregor, C.; Modi, S.; Campone, M.; Ma, B.; Kittaneh, M.; Dirix, L.; Motta, M.; Zhang, V.; Bhansali, S.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Ex vivo treatment response of primary tumors and/or associated metastases for preclinical and clinical development of therapeutics
    Journal Article

    Corben, A. D.; Uddin, M. M.; Crawford, B.; Farooq, M.; Modi, S.; Gerecitano, J.; Chiosis, G.; Alpaugh, M. L.
    Journal of Visualized Experiments (2014)

    Fulltext@MSK | Save
  • Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline
    Journal Article

    Giordano, S. H.; Temin, S.; Kirshner, J. J.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Esteva, F. J.; Gonzalez-Angulo, A. M.; Krop, I.; Levinson, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology Clinical Practice Guideline
    Journal Article

    Ramakrishna, N.; Temin, S.; Chandarlapaty, S.; Crews, J. R.; Davidson, N. E.; Esteva, F. J.; Giordano, S. H.; Gonzalez-Angulo, A. M.; Kirshner, J. J.; Krop, I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: A case series
    Journal Article

    Sibaud, V.; Niec, R. E.; Schindler, K.; Busam, K. J.; RocheĢ, H.; Modi, S.; Delord, J. P.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2014)

    Fulltext@MSK | Save
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions
    Journal Article

    Jhaveri, K.; Ochiana, S. O.; Dunphy, M. P. S.; Gerecitano, J. F.; Corben, A. D.; Peter, R. I.; Janjigian, Y. Y.; Gomes DaGama, E. M.; Koren, J. 3rd; Modi, S.; more...
    Expert Opinion on Investigational Drugs (2014)

    Fulltext@MSK | Save
  • Using (124)I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Gajria, D.; Taldone, T.; Alpaugh, M.; DaGama, E. G.; Uddin, M.; Chiosis, G.; Lewis, J. S.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Results from a phase 2a study of trastuzumab emtansine, paclitaxel, and pertuzumab in patients with HER2-positive metastatic breast cancer
    Meeting Abstract

    Elias, A.; Modi, S.; Krop, I. E.; Pegram, M.; Ipe, D.; Guardino, E. A.; Althaus, B.; LoRusso, P. L.
    Cancer Research (2013)

    Fulltext@MSK | Save